StockData
GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31

GE HealthCare Technologies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$69.76+0.19 (+0.27%)

Close on Oct 19, 2026

Market cap
$31.67B
P/E (TTM)
16.0
Dividend yield
0.20%

Earnings

Next report expected Oct 28, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 23, 2026During market hours$5.30B––
Q1 FY2026
Ended Mar 31, 2026
Apr 29, 2026Before market open$5.10B$0.85$0.99
Q4 FY2025
Ended Dec 31, 2025
Feb 4, 2026Before market open$5.70B$1.29$1.44
Q3 FY2025
Ended Sep 30, 2025
Oct 29, 2025Before market open$5.10B$0.98$1.07
Q2 FY2025
Ended Jun 30, 2025
Jul 30, 2025Before market open$5.00B$1.06$1.06
Q1 FY2025
Ended Mar 31, 2025
Apr 30, 2025Before market open$4.80B$1.23$1.01
Q4 FY2024
Ended Dec 31, 2024
Feb 13, 2025Before market open$5.30B$1.57$1.45
Q3 FY2024
Ended Sep 30, 2024
Oct 30, 2024Before market open$4.90B$1.02$1.14
Q2 FY2024
Ended Jun 30, 2024
Jul 31, 2024Before market open$4.80B$0.93$1.00
Q1 FY2024
Ended Mar 31, 2024
Apr 30, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 6, 2024Before market open–––

Company guidance

Outlook given with results on Apr 29, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Adjusted EPS*non-GAAPfull-year 2026$4.80 to $5.00Lowered
Free cash flow*non-GAAPfull-year 2026$1.60BLowered
Adjusted EBIT margin*non-GAAPfull-year 202615.4% to 15.7%Lowered
Adjusted effective tax rate (ETR)*non-GAAPfull-year 202620% to 21%Maintained
Organic revenue growth*non-GAAPfull-year 20263% to 4% growthMaintained

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements GE HealthCare Technologies filed with the SEC